What happens to the cryomapping process at -32°C?

In the context of the cryomapping process, when the temperature reaches -32°C, the primary function is to assess the viability and position of the potential ablation target before proceeding with the full procedure. This stage of cooling allows the medical team to analyze electrical activity in the targeted tissue without causing irreversible damage.

The cryomapping process utilizes this temperature to temporarily freeze the area of interest and observe any changes in the cardiac electrical signals, helping to ensure that the ablation approach is precise and effective. This testing phase is crucial for identifying the precise locations for ablation, as it provides real-time feedback on how the tissues respond to extreme cold without committing to permanent alterations.

This approach enhances the overall safety and efficacy of the ablation procedure by ensuring that the treatment is directed accurately, mitigating risks associated with unnecessary ablation of non-targeted tissues.